3 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 3, Recruiting 2, Active not recruiting 1, Unknown 1 |
Follow Patient Preference: new trials by email Literature Review of Patient Preference trials Research Report on Patient Preference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System Ultra Rapid Lispro (URLi), Insulin pump with continuous glucose monitoring (CGM) - Type 1 Diabetes (T1D) | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 50 | 2024-10-06 | 2024-09-24 |
| Methotrexate in Patients with Early Rheumatoid Arthritis Methotrexate - Rheumatoid Arthritis | Phase 4 | Active not recruiting | Region Västerbotten | 212 | 2022-04-28 | 2025-01-14 |
| The PRIME Study: A Randomized, Controlled, Prospective Study Dextenza, Topical Prednisolone - Patient Preference, Patient Outcomes | Phase 4 | Recruiting | Vance Thompson Vision - MT | 20 | 2020-09-14 | 2020-09-16 |
| A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery Dexamethasone, Standard of care surgery - Patient Preference | Phase 4 | Recruiting | Ophthalmic Consultants of Long Island | 50 | 2019-11-04 | 2019-12-20 |
| Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications Vildagliptin/ Metformin, Liraglutide, Metformin - Type 2 Diabetes | Phase 4 | Completed | Novartis Pharmaceuticals | 62 | 2012-01-01 | 2017-02-27 |
| Study to Evaluate Effectiveness of Aranesp® Aranesp® - Kidney Disease | Phase 4 | Completed | Amgen | 2011-01-21 | ||
| Aranesp® Monthly Preference Study - 2 Aranesp® - Kidney Disease | Phase 4 | Completed | Amgen | 2008-09-30 |
Kidney Diseases (2) · Renal Insufficiency, Chronic (2) · Arthritis, Rheumatoid (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1)
Behavior (7) · Health Behavior (7) · Patient Satisfaction (7) · Treatment Adherence and Compliance (7) · Autoimmune Diseases (2) · Chronic Disease (2) · Diabetes Mellitus (2) · Disease Attributes (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glucose Metabolism Disorders (2) · Immune System Diseases (2) · Male Urogenital Diseases (2) · Metabolic Diseases (2)
Darbepoetin alfa (2) · Calcium Dobesilate (1) · Continuous Glucose Monitoring (1) · Dexamethasone (1) · Ketorolac (1) · Liraglutide (1) · Metformin (1) · Methotrexate (1) · Moxifloxacin (1) · Prednisolone (1) · Vildagliptin (1)
Amgen (2) · Novartis Pharmaceuticals (1) · Ophthalmic Consultants of Long Island (1) · Region Västerbotten (1) · Tel-Aviv Sourasky Medical Center (1) · Vance Thompson Vision - MT (1)
United States (2) · Germany (1) · Israel (1) · Sweden (1)
PMID 26301063, PMID 28895431, PMID 30224348, PMID 33687783, PMID 35403792, PMID 36058207, PMID 36598841, PMID 38377327